Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508-15 Reply

被引:0
|
作者
D'Andrea, David [1 ]
Soria, Francesco [2 ]
Hurle, Rodolfo [3 ]
Enikeev, Dmitry [1 ,4 ]
Kotov, Sergey [5 ]
Regnier, Sophie [6 ]
Xylinas, Evanguelos [6 ]
Lusuardi, Lukas [7 ]
Heidenreich, Axel [8 ]
Cai, Chao [9 ]
Frego, Nicola [3 ]
Taraktin, Mark [4 ]
Ryabov, Maxim [10 ]
Gontero, Paolo [2 ]
Comperat, Eva [11 ]
Shariat, Shahrokh F. [1 ,12 ,13 ,14 ]
机构
[1] Med Univ Vienna, Dept Urol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[2] Torino Sch Med, AOU Citta & Salute Sci, Dept Surg Sci, Div Urol, Turin, Italy
[3] IRCCS Human Clin & Res Hosp, Dept Urol, Rozzano, Italy
[4] Sechenov Univ, Inst Urol & Reprod Hlth, Moscow, Russia
[5] Pirogov Russian Natl Res Med Univ, Dept Urol & Androl, Moscow, Russia
[6] Univ Paris Cite, Bichat Claude Bernard Hosp, AP HP, Dept Urol, Paris, France
[7] Paracelsius Med Univ, Dept Urol & Androl, Salzburg, Austria
[8] Univ Cologne, Dept Urol, Urooncol Robot Assisted & Specialized Surg, Cologne, Germany
[9] First Affiliated Hosp Guangzhou Med Univ, Dept Urol, Guangzhou, Peoples R China
[10] MEDSI, Dept Urol, Moscow, Russia
[11] Med Univ Vienna, Dept Pathol, Vienna, Austria
[12] Univ Texas Southwestern Med Ctr, Dept Urol, Dallas, TX USA
[13] Weill Cornell Med Coll, Dept Urol, New York, NY USA
[14] Charles Univ Prague, Fac Med 2, Dept Urol, Prague, Czech Republic
来源
EUROPEAN UROLOGY ONCOLOGY | 2024年 / 7卷 / 03期
关键词
TRANSURETHRAL RESECTION;
D O I
10.1016/j.euo.2023.10.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:639 / 640
页数:2
相关论文
共 6 条
  • [1] Re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. 2023;6:508-515
    Lombardo, Riccardo
    Riolo, Sara
    De Nunzio, Cosimo
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (04): : 965 - 966
  • [2] Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. 2023;6:508-515
    D'Andrea, David
    Soria, Francesco
    Hurle, Rodolfo
    Enikeev, Dmitry
    Kotov, Sergey
    Regnier, Sophie
    Xylinas, Evanguelos
    Lusuardi, Lukas
    Heidenreich, Axel
    Cai, Chao
    Frego, Nicola
    Taraktin, Mark
    Ryabov, Maxim
    Gontero, Paolo
    Comperat, Eva
    Shariat, Shahrokh F.
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (04): : 967 - 968
  • [3] Letter to the Editor Re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010
    Montorsi, Francesco
    Rosiello, Giuseppe
    Gandaglia, Giorgio
    Salonia, Andrea
    Briganti, Alberto
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03):
  • [4] Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9
    Soria, Francesco
    D'Andrea, David
    Gontero, Paolo
    Shariat, Shahrokh F.
    [J]. EUROPEAN UROLOGY FOCUS, 2022, 8 (02): : 633 - 634
  • [5] Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscleInvasive Bladder Cancer Treated with Bacillus CalmetteGuérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596
    Contieri, Roberto
    Hensley, Patrick J.
    Kamat, Ashish M.
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (02): : 301 - 301
  • [6] Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean FP Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer
    Lestingi, Jean F. P.
    Quoc-Dien Trinh
    Coelho, Rafael F.
    Pontes, Jose, Jr.
    Bastos, Diogo A.
    Nahas, William C.
    [J]. EUROPEAN UROLOGY, 2021, 79 (06) : E184 - E185